Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riad Dirani

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Population Health Management|October 26, 2013
Cost of schizophrenia in the Medicare programRachel Feldman, Robert A Bailey, James Muller, et al.
Bipolar Disorders|January 10, 2003
Pharmacotherapy patterns in the treatment of bipolar disorderPatricia Russo, Mark W Smith, Riad Dirani, et al.
Journal of Occupational and Environmental Medicine|April 12, 2007
An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessationKenneth C Jackson, Robert Nahoopii, Qayyim Said, et al.
Journal of Medical Economics|December 8, 2009
Workplace productivity, employment issues, and resource utilization in patients with bipolar I disorderBarbara J McMorris, Kristen E Downs, Jessica M Panish, et al.
Treatments in Respiratory Medicine|July 1, 2006
Evaluating Diagnosis and Treatment Patterns of COPD in Primary CareVijay N Joish, Ellen Brady, William Stockdale, et al.
Current Medical Research and Opinion|June 24, 2011
Changes in schizophrenia-related hospitalization and ER use among patients receiving paliperidone palmitate: results from a clinical trial with a 52-week open-label extension (OLE)Chris M Kozma, Terra Slaton, Riad Dirani, et al.
The American Journal of Managed Care|October 9, 2014
Medicaid prior authorization policies and imprisonment among patients with schizophreniaDana Goldman, John Fastenau, Riad Dirani, et al.
General Hospital Psychiatry|May 24, 2011
Prevalence of liver disease in veterans with bipolar disorder or schizophreniaBret E Fuller, Veronica L Rodriguez, Alex Linke, et al.
Health Affairs (Project Hope)|December 8, 2011
Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychoticsWilliam B Vogt, Geoffrey Joyce, Jing Xia, et al.
Journal of Occupational and Environmental Medicine|May 1, 2010
Indirect costs associated with nonadherence to treatment for bipolar disorderErin Bagalman, Kristina S Yu-Isenberg, Emily Durden, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Population Health Management|October 26, 2013
Cost of schizophrenia in the Medicare programRachel Feldman, Robert A Bailey, James Muller, et al.
Bipolar Disorders|January 10, 2003
Pharmacotherapy patterns in the treatment of bipolar disorderPatricia Russo, Mark W Smith, Riad Dirani, et al.
Journal of Occupational and Environmental Medicine|April 12, 2007
An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessationKenneth C Jackson, Robert Nahoopii, Qayyim Said, et al.
Journal of Medical Economics|December 8, 2009
Workplace productivity, employment issues, and resource utilization in patients with bipolar I disorderBarbara J McMorris, Kristen E Downs, Jessica M Panish, et al.
Treatments in Respiratory Medicine|July 1, 2006
Evaluating Diagnosis and Treatment Patterns of COPD in Primary CareVijay N Joish, Ellen Brady, William Stockdale, et al.
Current Medical Research and Opinion|June 24, 2011
Changes in schizophrenia-related hospitalization and ER use among patients receiving paliperidone palmitate: results from a clinical trial with a 52-week open-label extension (OLE)Chris M Kozma, Terra Slaton, Riad Dirani, et al.
The American Journal of Managed Care|October 9, 2014
Medicaid prior authorization policies and imprisonment among patients with schizophreniaDana Goldman, John Fastenau, Riad Dirani, et al.
General Hospital Psychiatry|May 24, 2011
Prevalence of liver disease in veterans with bipolar disorder or schizophreniaBret E Fuller, Veronica L Rodriguez, Alex Linke, et al.
Health Affairs (Project Hope)|December 8, 2011
Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychoticsWilliam B Vogt, Geoffrey Joyce, Jing Xia, et al.
Journal of Occupational and Environmental Medicine|May 1, 2010
Indirect costs associated with nonadherence to treatment for bipolar disorderErin Bagalman, Kristina S Yu-Isenberg, Emily Durden, et al.
Pageof 4